MARIETTA, GA (PRWEB) JUNE 15, 2016
Amendia (http://www.amendia.com), a leading provider of innovative spinal technologies, is pleased to announce the commercial launch of its latest new technology, the Ceres™-C Stand-alone Cervical Interbody.
The Ceres-C is a low-profile polyetheretherketone (PEEK) interbody spacer combined with a titanium plate and screws. Designed for anterior cervical interbody fusions, the technology is indicated for use in skeletally mature patients with degenerative disc disease (DDD) with accompanying radicular symptoms at one level from C2-T1.
“The Ceres-C is the latest addition to our comprehensive product offerings,” says Lawrence Boyd, Ph.D., Executive Vice President of Research & Development. “In addition to the potential to reduce operating time, it provides surgeons with a versatile new cervical technology with considerable flexibility and usability in the operating room.”
The cervical stand-alone interbody utilizes a cam locking mechanism designed to minimize steps and save valuable OR time. Dual cam locks featured in the titanium plate prevent screw back-out. The combination of the biased screw angles and fixed and variable screw options allows for either a rigid or semi-rigid construct. Multiple sizes and lordotic options are available to help achieve optimal surgical placement.
“The Ceres-C stand-alone device is a simple, no steps wasted method of cervical fixation with a minimal anterior profile. The intraoperative capabilities of the Ceres-C system allow surgeons to make implant and fixation decisions while in surgery thus eliminating multiple sets and trays,” says Dr. Krzysztof Siemionow, Chief of Spine Surgery and Assistant Professor of Orthopaedics and Neurosurgery at University of Illinois Hospital.
In addition to the Ceres-C, Amendia is planning to launch an innovative range of cervical plates later this month.
Headquartered in a state-of-the-art manufacturing facility in Marietta, Georgia, Amendia is a leading designer, developer, manufacturer and marketer of medical devices used in spinal surgical procedures. Amendia’s mission is to exceed surgeon and patient expectations by creating balanced solutions with disruptive technologies for medical devices paired with biologics and instrumentation. Amendia’s vertically-integrated strategy focuses on improving surgical outcomes and the lives of patients with spinal disorders. For more information, please visit http://www.amendia.com.